Europe Immunology Drugs Market Report 2017

Besides the typical market data found above you will be able to discover how these diseases have been trending over time, their epidemiology, drivers and limiters of these markets, Porter’s Five Forces analysis, clinical trials, a pipeline of products coming out soon, mergers and acquisitions, company profiles and SWOT analyses.

Key Topics Covered:

Report Guidance

Market Definition

Research Methodology

Executive Summary

Disease Overview
Rheumatoid Arthritis
Crohn’s Disease
Ankylosing Spondylitis
Psoriasis
Ulcerative Colitis

Product Assessment
Clinical Trials Overview
Pipeline Analysis
Promising new drugs for Ankylosing Spondylitis in the pipeline
Promising new drugs for Crohn’s Disease in the pipeline
Promising new drugs for Psoriasis in the pipeline
Promising new drugs for Rheumatoid Arthritis in the pipeline
Key Marketed Products Portfoilo
Orencia (abatacept)
Humira (adalimumab)
Cimzia (certolizumab)
Enbrel (etanercept)
Benepali (etanercept)
Simponi (golimumab)
Remicade (infliximab) + Remsima/Inflectra (infliximab)
Inflectra (infliximab)
Flixabi (infliximab)
Rituxan (rituximab)
Actemra/RoActemra (toclizumab)
XELJANZ (tofacitnib)
Kineret (anakinra)
Stelara (ustekinumab)
Entyvio (vedolizumab)
Tysabri (natalizumab)
Cosentyx (secukinumab)
Taltz (ixekizumab)

Drug Cost Analysis

Europe Immunology Market Overview
Introduction
Currency Exchange Rate

Europe Immunology Market – By Diseases
Market Overview
Rheumatoid Arthritis
Crohn’s Disease
Ankylosing Spondylitis
Psoriasis
Ulcerative Colitis

Europe Immunology Market – By Treatments
Market Overview
Biologics (Biologic DMARDS)
Non-biologics (corticosteroids, NSAIDs, tDMARDS & other non-biologic)

Europe Immunology Biologics Segment Analysis – By Drugs
Rheumatoid Arthritis Drugs
Crohn’s Disease Drugs
Ankylosing Spondylitis Drugs
Psoriasis Drugs
Ulcerative Colitis Drugs

Europe Immunology Biologics Segment Analysis – By Mechanism Of Action (MOA)
TNF
JFK
Others